{"title":"Risk of hospital readmission in patients with psychotic symptoms and a history of drug use","authors":"Paula Mollà Roig","doi":"10.1016/j.psiq.2024.100509","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Substance use is common in patients with psychotic symptomatology, especially in patients diagnosed with a first psychotic episode or schizophrenia. In both chronic psychosis and first psychotic episodes, substance abuse is associated with a worse outcome and a higher relapse rate.</div></div><div><h3>Methods</h3><div>For this study, a sample of <em>n</em> <!-->=<!--> <!-->731 was collected, including all patients hospitalised in the Adult Hospitalisation Unit (AHU) of Psychiatry of the Hospital Clínico Universitario de Zaragoza between 1 January 2014 and 31 December 2017, with a discharge diagnosis of psychotic disorder or affective disorder with psychotic symptomatology.</div></div><div><h3>Results</h3><div>From the analysis of the sample, the results show that 52.19% of the patients in the sample studied have a history of drug use. And, the most frequently used substance among patients with psychotic pathology is cannabis (73.71%). Likewise, patients with a history of drug use were admitted at an earlier age (35.07<!--> <!-->±<!--> <!-->12.72 years) than those without a history of drug use (50.74<!--> <!-->±<!--> <!-->15.08 years). In addition, drug use was more frequent in males, with a ratio of 4:1.</div></div><div><h3>Conclusions</h3><div>It has also been observed that patients with a history of drug use have a higher risk of hospital readmission to a psychiatric unit. In the sample analysed, cannabis was the only substance that presented statistically significant differences with respect to the risk of hospital readmission.</div></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psiquiatria Biologica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134593424000691","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Substance use is common in patients with psychotic symptomatology, especially in patients diagnosed with a first psychotic episode or schizophrenia. In both chronic psychosis and first psychotic episodes, substance abuse is associated with a worse outcome and a higher relapse rate.
Methods
For this study, a sample of n = 731 was collected, including all patients hospitalised in the Adult Hospitalisation Unit (AHU) of Psychiatry of the Hospital Clínico Universitario de Zaragoza between 1 January 2014 and 31 December 2017, with a discharge diagnosis of psychotic disorder or affective disorder with psychotic symptomatology.
Results
From the analysis of the sample, the results show that 52.19% of the patients in the sample studied have a history of drug use. And, the most frequently used substance among patients with psychotic pathology is cannabis (73.71%). Likewise, patients with a history of drug use were admitted at an earlier age (35.07 ± 12.72 years) than those without a history of drug use (50.74 ± 15.08 years). In addition, drug use was more frequent in males, with a ratio of 4:1.
Conclusions
It has also been observed that patients with a history of drug use have a higher risk of hospital readmission to a psychiatric unit. In the sample analysed, cannabis was the only substance that presented statistically significant differences with respect to the risk of hospital readmission.
期刊介绍:
Es la Publicación Oficial de la Sociedad Española de Psiquiatría Biológica. Los recientes avances en el conocimiento de la bioquímica y de la fisiología cerebrales y el progreso en general en el campo de las neurociencias han abierto el camino al desarrollo de la psiquiatría biológica, fundada sobre bases anatomofisiológicas, más sólidas y científicas que la psiquiatría tradicional.